Skip to main content
SpringerLink
Log in

Pulmonary pharmacology of WAY-126299A: A dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist

  • V. Pulmonary inflammation
  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993;147:S20–4.

    PubMed  Google Scholar 

  2. Grimes D, Sturm RJ, Marinari LR, Carlson RP, Berkenkopf JW, Musser JH, et al. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity. Europ J Pharmacol 1993;236:217–28.

    Google Scholar 

  3. Heaslip RJ, Grimes D, Berkenkopf JW, Ilsemann BA, Sickels BD, Weichman BM. Anti-leukotriene effects of WY-50,295 tromethamine in isolated pulmonary tissues. Europ J Pharmacol 1993;234:247–54.

    Google Scholar 

  4. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, et al. 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991;256:929–37.

    PubMed  Google Scholar 

  5. Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Intern Med 1993;119:1059–66.

    PubMed  Google Scholar 

  6. Malo PE, Bell RL, Shaughnessy TK, Summers JB, Brooks DW, Carter GW. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis. Pulm Pharmacol 1994;7:73–9.

    PubMed  Google Scholar 

  7. Carlson RP, Hartman DA, Tomchek LA, Walter TL, Lugay JR, Calhoun W, et al. Rapamycin, a potential disease-modifying antiarthritic drug. J Pharmacol Exp Ther 1993;266:1125–38.

    PubMed  Google Scholar 

  8. Howell RE, Sickels BD, Woeppel SL, Jenkins LP, Rubin EB, Weichman BM. Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs. J Pharmacol Exp Ther 1994;268:353–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wyeth-Ayerst Research, 08543-8000, Princeton, NJ, USA

    R. E. Howell, L. P. Jenkins, D. A. Hartman, W. B. Gray, D. Kubrak, R. P. Carlson, A. F. Kreft & D. Grimes

Authors
  1. R. E. Howell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. P. Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. A. Hartman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. B. Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Kubrak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. P. Carlson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. F. Kreft
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Grimes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howell, R.E., Jenkins, L.P., Hartman, D.A. et al. Pulmonary pharmacology of WAY-126299A: A dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist. Inflamm Res 44 (Suppl 2), S170–S171 (1995). https://doi.org/10.1007/BF01778316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01778316

Keywords

Search

Navigation